论文部分内容阅读
目的探讨自体LAK细胞回输疗法的作用机制。方法用MTT比色法检测29例慢性活动型乙型肝炎(CAH)患者及14例正常人外周血NK及LAK细胞活性;检测21例自体LAK细胞回输治疗前、后CAH患者外周血NK及LAK细胞活性。结果CAH患者NK及LAK细胞活性较正常人低,差异有显著性(P<0.01);治疗后较治疗前NK及LAK细胞活性增高,差异有显著性(P<0.01)。结论自体LAK细胞回输疗法治疗CAH有效,其作用机制之一是提高了CAH患者的NK及LAK细胞活性。
Objective To explore the mechanism of autologous LAK cell transfusion therapy. Methods MTT assay was used to detect the activity of NK and LAK in peripheral blood of 29 patients with chronic active hepatitis B (CAH) and 14 normal controls. The levels of NK and LAK in 21 patients with CAH before and after LAK transplantation LAK cell activity. Results The activity of NK and LAK in CAH patients was lower than that in normal people (P <0.01). The activity of NK and LAK cells in CAH patients was higher than that before treatment (P <0.01). Conclusions Autologous LAK cell transfusion therapy is effective in treating CAH. One of its mechanisms is to improve the activity of NK and LAK cells in CAH patients.